Case-Based Roundtable

Erik Domingues leads a vital discussion on innovative vitiligo management, addressing treatment challenges and psychosocial impacts in diverse patient populations.

At a recent Case-Based Roundtable event, Harrison Nguyen, MD, MBA, MPH, reviewed 2 HS patient cases and discussed the role of biologics.

Experts discuss real-world strategies for managing alopecia areata, emphasizing JAK inhibitors, psychosocial impacts, and personalized patient care approaches.

In part 3 of this Case-Based Roundtable supplement, experts discuss psoriatic therapies for hair-baring areas.

At a recent Case-Based Roundtable® event, Aaron Farberg, MD, moderated a discussion of challenging atopic dermatitis cases spanning adult, adolescent, and pediatric patients.

Porter leads a dynamic roundtable on hidradenitis suppurativa, exploring innovative treatments and collaborative strategies for improved patient outcomes.

In part 2 of this Case-Based Roundtable supplement, experts discuss therapeutic options for psoriasis when considering involvement of special areas.

In part 1 of this Case-Based Roundtable supplement, experts discuss biologic treatment options for psoriasis and balancing efficacy with patient needs.

At a Dermatology Times Case-Based Roundtable event, Joe Gorelick, MSN, FNP-C, reviewed real-world strategies for hidradenitis suppurativa, highlighting growing preference for bimekizumab based on its dual IL-17A/IL-17F inhibition.

Arash Mostaghimi, MD, MPH, FAAD, and experts discuss evolving treatment standards for alopecia areata, focusing on JAK inhibitors, patient-centered care, and future therapeutic innovations.

Participants agreed that HS is rarely controlled with monotherapy and often requires coordinated multimodal care.

At a Case-Based Roundtable event, Cory Rubin, MD, discussed real-world strategies for optimizing systemic therapy in patients with moderate to severe psoriasis.

Explore innovative acne management strategies from James Del Rosso, DO, focusing on personalized treatments and patient education for effective results in diverse cases.

Explore real-world strategies with Leigh Ann Pansch, MSN, FNP-BC, DCNP, for managing psoriasis, emphasizing patient-centered care, and implementing individualized biologic treatment approaches.

At a recent Dermatology Times Case-Based Roundtable event, John Browning, MD, led a discussion on evolving strategies for atopic dermatitis management.

Andrew Mastro, MS, PA-C, moderated a recent Dermatology Times Case-Based Roundtable event to present 3 complex cases of moderate to severe psoriasis treated with biologics.

Through 3 complex cases, participants explored practical ways to integrate agents like clascoterone and tazarotene into daily practice.

Mark Kaufmann, MD, discusses how patient realities shape psoriasis treatment choices.

During a Case-Based Roundtable event, Naiem Issa, MD, PhD, guided colleagues through 3 complex atopic dermatitis cases, highlighting how modern topicals can deliver rapid and durable control across age groups.

Explore real-world psoriasis management insights from Anthony Nuara, MD, PhD, focusing on patient-centered approaches and innovative treatments like tildrakizumab.

Todd Schlesinger, MD, FAAD, FASMS, moderated an engaging discussion with colleagues to discuss complex vitiligo cases during a Dermatology Times Case-Based Roundtable event.

Rebecca Smith, MD, recently led a Dermatology Times Case-Based Roundtable event on complex cases in atopic dermatitis.

Tiffany Mayo, MD, recently moderated a Dermatology Times Case-Based Roundtable event to discuss topical innovation, systemic options, and patient-centered factors when treating atopic dermatitis.

Experts in Miami Beach emphasized that adherence often drives biologic choice more than efficacy in real-world psoriasis care.

Roundtable participants agreed the art of psoriasis management lies in aligning biologic or oral options with patient comorbidities, lifestyle, and insurance coverage.